A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Condition:   Type2 Diabetes Interventions:   Drug: Metformin≥1000mg;   Drug: Pioglitazone 15mg;   Drug: Pioglitazone 30 mg;   Drug: Pioglitazone 15mg Placebo;   Drug: Pioglitazone 30mg Placebo;   Drug: Dapagliflozin 10mg Sponsor:   Boryung Pharmaceutical Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials